Pharmacology and Molecular Sciences Training Program: Enhancing Inclusivity Through Universal Design for Learning in Graduate Courses
药理学和分子科学培训计划:通过研究生课程学习的通用设计增强包容性
基本信息
- 批准号:10592034
- 负责人:
- 金额:$ 8.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Project Summary
The aim of this supplement to the Pharmacology and Molecular Sciences T32 training program
is to accelerate efforts to promote inclusive learning in biomedical graduate courses at Johns
Hopkins University (JHU), through implementation of Universal Design for Learning (UDL)
approaches. There is institutional support for students who need accommodations in courses.
However, not all students make these requests, and such accommodations do not extend to other
students who may also benefit from them. UDL is a framework to guide the design of learning
goals, as well as course materials, delivery and assessments, in a way that accommodates
learners from different backgrounds and with diverse learning preferences. Designing courses to
provide content in an accessible way as a default for all students increases inclusivity, reducing
the need for special accommodations and avoiding singling-out students with documented
disabilities. We strive for such inclusive learning environments, however, competing demands on
faculty create real barriers to implementing UDL best practices into courses, which we intend to
address through this supplement. To maximize the initial impact of this project at JHU, we will
implement inclusive practices in graduate courses which are team-taught by faculty from multiple
departments and taken by students in other training programs. The objectives of the project are
to promote awareness in many JHU programs of how UDL enhances inclusivity, and to provide
direct support in revising course materials and delivery. In collaboration with an Instructional
Designer, we will engage course directors, faculty instructors and TAs in a targeted, structured
way to lower the barrier to UDL implementation by: 1) educating on UDL rationale and concepts,
and available resources, 2) providing specific guidance on course design and delivery, and 3)
helping course directors and instructors with transition of course materials and delivery to
accessible formats. The proposed activities are a key catalyst to surmount initial barriers of
transforming courses and creating the platform to educate faculty and TAs and impart skills that
they can build on. Participating faculty and TAs will serve as ambassadors within their
departments and programs. Together with an established educational platform and institutional
support, this will impact many T32 programs at JHU in a sustainable way to ensure UDL best
practices in all courses.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Caren L. Freel Meyers其他文献
Investigating inhibitors of 1-deoxy-span class="small-caps"d/span-xylulose 5-phosphate synthase in a mouse model of UTI
在 UTI 的小鼠模型中研究 1-脱氧-D-木酮糖 5-磷酸合酶的抑制剂
- DOI:
10.1128/spectrum.03896-23 - 发表时间:
2024-03-14 - 期刊:
- 影响因子:3.800
- 作者:
Eric C. Chen;Rachel L. Shapiro;Arindom Pal;David Bartee;Kevin DeLong;Davell M. Carter;Erika Serrano-Diaz;Rana Rais;Laura M. Ensign;Caren L. Freel Meyers - 通讯作者:
Caren L. Freel Meyers
Caren L. Freel Meyers的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Caren L. Freel Meyers', 18)}}的其他基金
Toward understanding the chemistry and biology of microbial DXP synthase
了解微生物 DXP 合酶的化学和生物学
- 批准号:
10641824 - 财政年份:2021
- 资助金额:
$ 8.63万 - 项目类别:
Targeting DXP synthase in bacterial metabolism
靶向细菌代谢中的 DXP 合酶
- 批准号:
10576858 - 财政年份:2021
- 资助金额:
$ 8.63万 - 项目类别:
Targeting DXP synthase in bacterial metabolism
靶向细菌代谢中的 DXP 合酶
- 批准号:
10372207 - 财政年份:2021
- 资助金额:
$ 8.63万 - 项目类别:
Toward understanding the chemistry and biology of microbial DXP synthase
了解微生物 DXP 合酶的化学和生物学
- 批准号:
10470350 - 财政年份:2021
- 资助金额:
$ 8.63万 - 项目类别:
Toward understanding the chemistry and biology of microbial DXP synthase
了解微生物 DXP 合酶的化学和生物学
- 批准号:
10317255 - 财政年份:2021
- 资助金额:
$ 8.63万 - 项目类别:
Pharmacology and Molecular Sciences Training Program
药理学和分子科学培训计划
- 批准号:
10197160 - 财政年份:2020
- 资助金额:
$ 8.63万 - 项目类别:
Pharmacology and Molecular Sciences Training Program
药理学和分子科学培训计划
- 批准号:
10617205 - 财政年份:2020
- 资助金额:
$ 8.63万 - 项目类别:
Pharmacology and Molecular Sciences Training Program
药理学和分子科学培训计划
- 批准号:
10385766 - 财政年份:2020
- 资助金额:
$ 8.63万 - 项目类别:
相似国自然基金
Kidney injury molecular(KIM-1)介导肾小管上皮细胞自噬在糖尿病肾病肾间质纤维化中的作用
- 批准号:81300605
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
Molecular Plant
- 批准号:31224801
- 批准年份:2012
- 资助金额:20.0 万元
- 项目类别:专项基金项目
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
Molecular Plant
- 批准号:31024802
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:专项基金项目
Cellular & Molecular Immunology
- 批准号:30824806
- 批准年份:2008
- 资助金额:20.0 万元
- 项目类别:专项基金项目
相似海外基金
Nanobody- and mini-G protein-enabled molecular pharmacology of HCAR1
HCAR1 的纳米抗体和迷你 G 蛋白分子药理学
- 批准号:
10666999 - 财政年份:2023
- 资助金额:
$ 8.63万 - 项目类别:
Molecular pharmacology of Kv7 potassium channel activators
Kv7 钾通道激活剂的分子药理学
- 批准号:
462082 - 财政年份:2022
- 资助金额:
$ 8.63万 - 项目类别:
Operating Grants
Synthetic amatoxins for applications in targeted therapy and molecular pharmacology
用于靶向治疗和分子药理学应用的合成鹅膏毒素
- 批准号:
468969 - 财政年份:2022
- 资助金额:
$ 8.63万 - 项目类别:
Operating Grants
Exploiting a novel molecular toolkit to explore cell type specific adenosine receptor pharmacology and regulation at endogenous levels of expression.
利用新型分子工具包探索细胞类型特异性腺苷受体药理学和内源表达水平的调节。
- 批准号:
MR/W016176/1 - 财政年份:2022
- 资助金额:
$ 8.63万 - 项目类别:
Research Grant
Predoctoral Training Program in Molecular Pharmacology
分子药理学博士前培训项目
- 批准号:
10642662 - 财政年份:2022
- 资助金额:
$ 8.63万 - 项目类别:
Predoctoral Training Program in Molecular Pharmacology
分子药理学博士前培训项目
- 批准号:
10331450 - 财政年份:2022
- 资助金额:
$ 8.63万 - 项目类别:
Graduate Training in Molecular and Cellular Pharmacology
分子和细胞药理学研究生培训
- 批准号:
10175159 - 财政年份:2021
- 资助金额:
$ 8.63万 - 项目类别:
Human GRIA variants and neurological diseases: from molecular mechanism to rescue pharmacology
人类 GRIA 变异与神经系统疾病:从分子机制到救援药理学
- 批准号:
10288716 - 财政年份:2021
- 资助金额:
$ 8.63万 - 项目类别:
Molecular Pharmacology of the Lipid/pH-sensing GPCRs as modulators of immune cell function
脂质/pH 感应 GPCR 作为免疫细胞功能调节剂的分子药理学
- 批准号:
2689624 - 财政年份:2021
- 资助金额:
$ 8.63万 - 项目类别:
Studentship